T cell dynamics in HIV-1 infection

被引:424
作者
Douek, DC
Picker, LJ
Koup, RA
机构
[1] NIAID, Human Immunol Sect, NIH, Bethesda, MD 20892 USA
[2] NIAID, Vaccine Res Ctr, Immunol Lab, NIH, Bethesda, MD 20892 USA
[3] Oregon Hlth & Sci Univ, Vaccine Gene Therapy Inst, Beaverton, OR 97006 USA
关键词
T cells; activation; lymphopenia;
D O I
10.1146/annurev.immunol.21.120601.141053
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the absence of antiretroviral treatment, HIV-1 establishes a chronic, progressive infection of the human immune system that invariably, over the course of years, leads to its destruction and fatal immunodeficiency. Paradoxically, while viral replication is extensive throughout the course of infection, deterioration of conventional measures of immunity is slow, including the characteristic loss of CD4(+) T cells that is thought to play a key role in the development of immunodeficiency. This conundrum suggests that CD4(+) T cell-directed viral cytopathicity alone cannot explain the course of disease. Indeed, recent advances now indicate that HIV-1 pathogenesis is likely to result from a complex interplay between the virus and the immune system, particularly the mechanisms responsible for T cell homeostasis and regeneration. We review these data and present a model of HIV-1 pathogenesis in which the protracted loss of CD4(+) T cells results from early viral destruction of selected memory T cell populations, followed by a combination of profound increases in overall memory T cell turnover, damage to the thymus and other lymphoid tissues, and physiological limitations in peripheral CD4(+) T cell renewal.
引用
收藏
页码:265 / 304
页数:44
相关论文
共 337 条
[1]  
Ahsan N, 1998, SEMIN NEPHROL, V18, P422
[2]   NEF STIMULATES HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL DNA-SYNTHESIS [J].
AIKEN, C ;
TRONO, D .
JOURNAL OF VIROLOGY, 1995, 69 (08) :5048-5056
[3]   THE SCID-HU MOUSE AS A MODEL FOR HIV-1 INFECTION [J].
ALDROVANDI, GM ;
FEUER, G ;
GAO, LY ;
JAMIESON, B ;
KRISTEVA, M ;
CHEN, ISY ;
ZACK, JA .
NATURE, 1993, 363 (6431) :732-736
[4]   Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia [J].
Allen, TM ;
O'Connor, DH ;
Jing, PC ;
Dzuris, JL ;
Mothé, BR ;
Vogel, TU ;
Dunphy, E ;
Liebl, ME ;
Emerson, C ;
Wilson, N ;
Kunstman, KJ ;
Wang, XC ;
Allison, DB ;
Hughes, AL ;
Desrosiers, RC ;
Altman, JD ;
Wolinsky, SM ;
Sette, A ;
Watkins, DI .
NATURE, 2000, 407 (6802) :386-390
[5]   Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection [J].
Altfeld, M ;
Rosenberg, ES ;
Shankarappa, R ;
Mukherjee, JS ;
Hecht, FM ;
Eldridge, RL ;
Addo, MM ;
Poon, SH ;
Phillips, MN ;
Robbins, GK ;
Sax, PE ;
Boswell, S ;
Kahn, JO ;
Brander, C ;
Goulder, PJR ;
Levy, JA ;
Mullins, JI ;
Walker, BD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :169-180
[6]  
AMEISEN JC, 1995, ADV EXP MED BIOL, V374, P139
[7]   Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: A worst-case dynamic analysis [J].
Anderson, RW ;
Ascher, MS ;
Sheppard, HW .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 17 (03) :245-252
[8]   Early reduction of immune activation in lymphoid tissue following highly active HIV therapy [J].
Andersson, J ;
Fehniger, TE ;
Patterson, BK ;
Pottage, J ;
Agnoli, M ;
Jones, P ;
Behbahani, H ;
Landay, A .
AIDS, 1998, 12 (11) :F123-F129
[9]   Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue [J].
Anton, PA ;
Elliott, J ;
Poles, MA ;
McGowan, IM ;
Matud, J ;
Hultin, LE ;
Grovit-Ferbas, K ;
Mackay, CR ;
Chen, ISY ;
Giorgi, JV .
AIDS, 2000, 14 (12) :1761-1765
[10]   Dynamics of T cell responses in HIV infection [J].
Appay, V ;
Papagno, L ;
Spina, CA ;
Hansasuta, P ;
King, A ;
Jones, L ;
Ogg, GS ;
Little, S ;
McMichael, AJ ;
Richman, DD ;
Rowland-Jones, SL .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3660-3666